Dr. Deborah is a molecular biologist and a Research Scientist in the Interventions and Clinical Trials Department. Dr. joined the Institute in 2004 as MSc. Candidate, conducting her research on drug resistant genotypes of Plasmodium falciparum parasites for first line malaria treatment (SP) in comparison to new antimalarial drugs (combination therapy- ACT) expected to be deployed countrywide.

 

Log in to use Ginger Limited mode monotherapy ×